Vesselon

Vesselon acquires FDA-approved Lipid Microsphere Drug Imagent for therapeutic platform
Pharmaceutical Business Review
Thu, 08/8/19 - 11:30 pm
Vesselon
oncology
FDA
Imagent
liquid microspherePH